Dipyridamole potentiates the anti-aggregating effect of endothelium-derived relaxing factor.
暂无分享,去创建一个
Y. Makita | I. Sakuma | Y. Akaishi | K. Matsuno | H. Yasuda | T. Kobayashi | T. Miyazaki | M. Fukao | M. Makita
[1] C. Nathan,et al. Identification of arginine as a precursor of endothelium-derived relaxing factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[2] S. Moncada,et al. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. , 1988, Biochemical pharmacology.
[3] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.
[4] M. Ishikawa,et al. Endothelium‐dependent inhibition of platelet aggregation , 1986, British journal of pharmacology.
[5] David B. Leake,et al. Subcellular Localization of Adenosine Diphosphatase in Cultured Pig Arterial Endothelial Cells , 1982, Thrombosis and Haemostasis.
[6] U. Ryan,et al. Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery. , 1980, The Journal of clinical investigation.
[7] S Moncada,et al. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. , 1979, The New England journal of medicine.
[8] H. Hidaka,et al. Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors. , 1977, Molecular pharmacology.
[9] R. Berne,et al. Uptake and metabolism of adenosine by human erythrocyte ghosts. , 1972, The American journal of physiology.